Metabolomics in Drug Discovery

Metabolomics is being used in Drug Discovery and in development from lead compound discovery to post approval drug surveillance. Metabolomics can help in finding potential new sites for therapeutic intervention by identifying metabolic changes. Metabolomics can provide activity information about possible novel drugs and drug scaffolds, indicate interesting targets for drug development and suggest binding partners of compounds. Furthermore, metabolomics can be used for the discovery of novel natural products and in drug development. Metabolomics can enhance the discovery and testing of new drugs and provide insight into the on- and off-target effects of drugs.

  • Drug metabolism during drug design and development
  • Metabolites in identification of drug targets
  • Metabonomics in preclinical pharmaceutical discovery and development
  • Toxicology and drug metabolism
  • QSAR and ligand-receptor models
  • Applications in Drug Development

Related Conference of Metabolomics in Drug Discovery

December 10-11, 2020

2nd Pathology and Infectious Disease Conference

Dubai, UAE
March 18-19, 2021

12th Tissue Repair and Regeneration Congress

Abu Dhabi, UAE
March 28-29, 2021

11th Glycobiology World Congress

Vienna, Austria
June 11-12, 2021

25th Global Congress on Biotechnology

Berlin, Germany
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic
September 27-28, 2021

25th European Biotechnology Congress

Dublin, Ireland

Metabolomics in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in